NPFIT-NPO-GEN-IP-0067



[pic]

|Supplier Questionnaire | |

| |Programme |NPFIT |DOCUMENT RECORD ID KEY |

| |Sub-Prog / |e-Prescribing | |

| |Project | |NPFIT-EP-BS-0026.01 |

| |Prog. Director |Tim Donohoe |Status |Final |

| |Owner |Ann Slee |Version |1.0 |

| |Author |Ann Slee |Version Date |12th May 2008 |

Initial Supplier Questionnaire

Initial Supplier Questionnaire

The programme would like to better understand current ePrescribing systems that may be available for deployment within the NHS at this time and the functionality that they provide.

We are planning to run this process in two initial parts

– the first is the completion of this questionnaire to give a broad outline of system type/functionality available and

– second an invited, scripted demonstration of systems that have core functionality identified as being available at this time. This is planned for early-mid July and will involve demonstrations for front-line NHS staff at a venue specified by the programme.

It is intended that the results of this work be made available – subject to supplier agreement – to support the NHS in any future decision making.

You are invited to complete this questionnaire and return it to eprescribing@ by 6th June 2008.

If you have any questions about the content or the process please contact Ann Slee at ann.slee@

Many thanks for your help in undertaking this work.

INSTRUCTIONS FOR COMPLETION Reference: xxxxxxx

|1. |Please return via email by 5pm on Friday 6th June to eprescribing@nhs.uk |

|2. |Service providers MUST answer every question even if “Not relevant”. Failure to address any area may result in exclusion from the |

| |evaluation list. |

|3 |The applicant may attach, where appropriate, any supporting documents to this application marking clearly on all such documents the NHS|

| |reference number above, the name of the applicant and the number of the question in this application form to which the document refers.|

|4 |Any questions/clarifications should be directed to eprescribing@nhs.uk or ann.slee@ |

|1. Details |

|Details of the company/group |

|Full name |

|Address |

|Post Code |

|Tel No . |

|Fax No |

|Contact Name |

|Email address |

|2. Service Provider's Status |

|The company/group must specify below whether they are (please tick): |

| |

|Sole Trader Partnership |

| |

|Self Employed Public Company |

| |

|Private Company In Association With A Group |

| |

|Part Of A Holding Company Other. Please detail……………….. |

|3. Parent Company Information |

|Provide the name of the parent or holding company together with the names of other subsidiary companies of the parent or holding company. |

| |

|Parent Company |

| |

|Other Subsidiary Companies |

|4. Services Provided |

|Please provide a description of the ePrescribing system provided by the company and group: |

|Please describe the main features/functionality e.g. e-Prescribing, scheduling etc |

| |

| |

| |

| |

| |

|5. Legal Proceedings |

|State whether you are or have been subject to proceedings in relation to: |

|(please tick as appropriate) |

| |

|Bankruptcy Arrangements made with creditors |

| |

|Winding Up Suspended business activities |

| |

|Affairs being administered by a court Any analogous situation with creditors (Please Specify) |

| |

|Additional Information |

|6. Objectives |

|Having knowledge of the NHS Connecting for Health programme explain what you think are the key challenges for integrating ePrescribing into the |

|national solutions across the NHS and how you see your solution fitting in to this. |

| |

| |

| |

| |

| |

|7. Experience |

|Describe why your software should proceed to phase two of this process |

| |

| |

| |

|8. Locations |

|It may be necessary to carry out work anywhere in England and on multi-sites simultaneously. What specific challenges will this pose for your |

|group or company? |

| |

| |

|9. Other Products and Services |

|Please list other services and products provided by your group or company |

| |

| |

|10. Details of Current Clients using the software |

|Please provide a list of current clients using the software in a live environment with the number of users, dates and description of the |

|services to any NHS organisations. |

| |

|Types of services might include ePrescribing, specialist ePrescribing eg oncology, types of ePrescribing e.g. discharge, PAS, order comms etc. |

| |

|Where systems are not in use within the NHS please detail where they are being used and what you see as the challenges for making the system |

|available for NHS use including likely timescales. |

|Organisation |Number of Users and average number of |Date went live (live usage, not |Types of Services |

| |prescriptions written daily |pilot or testing) | |

| | | | |

|11. Number of Staff currently employed supporting/developing the software |

|Skills / Specialties |Qualifications |Number of People |

| | | |

| | | |

| | | |

|12. How are system developments identified? |

| User group |Other (please detail) |

| User suggestions | |

|13. How many releases/upgrades have there been in the last two years & what additional functionality became available at each release? |

|Release number & date |Functionality and/or fix details |

| | |

| | |

| | |

| | |

|14. What are the planned developments for the system in the next:- |

|12months |2 years |

| | |

|15. Which of these categories best describe your systems application architecture? (Tick all that apply) |

| Stand-alone |Please include additional information if appropriate: |

| | |

|Client / server | |

| | |

|Thin client (e.g. Cytrix) | |

| | |

|Browser based | |

| | |

|Other, please specify: | |

|16. Which client operating system platform(s) does your system use? |

| MS-DOS |Please include additional information if appropriate (e.g. 64 bit):|

| | |

|Windows 98/2000/NT/ME | |

| | |

|Windows XP | |

| | |

|Windows Vista | |

| | |

|Apple Macintosh | |

| | |

|UNIX / LINUX | |

| | |

|Other, please specify: | |

|17. Which server operating system platform(s) does your system use? |

| N/A (as a stand-alone system) |Please include additional information if appropriate (e.g. 64 bit):|

| | |

|Windows NT | |

| | |

|Windows 2000/2003 | |

| | |

|UNIX / LINUX | |

| | |

|Other, please specify: | |

|18. What user and site topology does your system support? |

| Single user / single site |Please include additional information if appropriate: |

| | |

|Multi user / single site | |

| | |

|Multi user / multi site | |

| | |

|If multi user, how many concurrent clinical users can the system support? | |

| | |

|1-5 6-10 11+ No technical limit | |

| | |

|Does your system support mobile devices such as hand-held PDAs, tablets? | |

|Yes No | |

| | |

|Can/could your system support mobile devices such as hand-held PDAs, | |

|tablets? Yes No | |

| | |

|Does your system support bar coding – please detail | |

|19. Which of these security and information governance features does your system support? |

| Single factor end-user authentication (e.g. username/password) |Please include additional information if appropriate: |

| | |

|Multi factor end-user authentication (e.g. username/password plus smartcard | |

|or dongle) | |

| | |

|Audit trail | |

| | |

|Inactivity screen lock-out | |

| | |

|Role based access control | |

| | |

|Secure/encrypted database | |

| | |

|Electronic signatures | |

|20. Which of these scalability and disaster recovery features does your system support? |

| Resilient hardware (e.g. RAID) |Please include additional information if appropriate: |

| | |

|Entire system dual hosting / load balancing | |

| | |

|Sub-system dual hosting / load balancing | |

| | |

|Hot stand-by environment | |

| | |

|Scheduled back-up | |

| | |

|System back-up to file/disk/tape | |

| | |

|Remote system administration | |

| | |

|Remote software upgrade | |

|21. Use of drug dictionaries for prescribing and clinical decision support. |

| |

|Does your system use a 3rd party or proprietary drug dictionary for prescribing? |

|Proprietary 3rd party – Please specify: |

| |

|Does your system use a 3rd party or proprietary drug database for clinical decision support? |

|Proprietary 3rd party – Please specify: |

| |

|Is your system compatible with the NHS Dictionary of Medicines and Devices (dm+d)? Yes No |

| |

|Please describe the clinical decision support functionality |

| |

| |

|Please include additional information if appropriate: |

| |

|22. Integration with other clinical or hospital systems. |

| |

|Does your system integrate with any other clinical or hospital systems? Please provide details where appropriate. |

| |

|Patient administration system |

| |

|Radiotherapy systems |

| |

|Pharmacy stock control |

| |

|Pharmacy compounding software |

| |

|Path lab |

| |

|Radiography |

| |

|Other systems – please specify: |

| |

|Please include additional information if appropriate: |

| |

|23. Has your system been developed to be NHS CfH compliant? What NHS CfH development do you have planned? |

|Compliant NHS CfH National Services; |Details of NHS CfH development planned: |

| | |

|PDS | |

| | |

|Choose and Book | |

| | |

|Electronic Prescription Service | |

| | |

|Other – please specify: | |

| | |

|Details of development undergone: | |

| | |

|24. Clinical content |

|Please describe what and how you would share clinical content locally, within networks and nationally |

| |

| |

|25. Please complete the embedded spreadsheet outlining the functional requirements that the NHS has identified as required within ePrescribing |

|systems. |

| |

|For each of the elements listed as priority 1 or 1-2 please annotate using the code number:- |

|1 = currently available within your system |

|2= planned release within the next 12 months |

|3= out of scope |

[pic]

|26. Please indicate whether you are interested in demonstrating your system at the clinical evaluation day planned in July? If not please give |

|reasons. |

| |

| |

| |

|Signed. ………………………………………………………. |

|Name in block letters |

|Position |

|For and on behalf of |

|Date |

| |

|(This must be signed by the applicant or a partner or an authorised representative in his / her own name and on behalf of the company / |

|organisation making this Application) |

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download